Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Michał Sienkiewicz, Andrzej Jaśkiewicz, Aleksandra Tarasiuk & Jakub Fichna. (2022) Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance. Critical Reviews in Food Science and Nutrition 62:22, pages 6016-6033.
Read now
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
Ariella Bar-Gil Shitrit, Benjamin Koslowsky, Dan M. Livovsky, David Shitrit, Kalman Paz, Tomer Adar, Samuel N. Adler & Eran Goldin. (2017) A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy. Scandinavian Journal of Gastroenterology 52:3, pages 328-333.
Read now
Read now
Andrea Hille, Margret Rave-Fränk, Hans Christiansen, Markus K. A. Herrmann, Tereza Kertesz, Robert M. Hermann, Hendrik A. Wolff, Markus Schirmer, Clemens F. Hess & Giuliano Ramadori. (2009) Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: Results of a prospective study. Scandinavian Journal of Gastroenterology 44:8, pages 939-946.
Read now
Read now
Articles from other publishers (54)
Dan Vălean, Roxana Zaharie, Roman Țaulean, Lia Usatiuc & Florin Zaharie. (2024) Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review. International Journal of Molecular Sciences 25:4, pages 2077.
Crossref
Crossref
Nisha E. Mathew, Delyse McCaffrey, Adam K. Walker, Kylie-Ann Mallitt, Anne Masi, Margaret J. Morris & Chee Y. Ooi. (2024) The search for gastrointestinal inflammation in autism: a systematic review and meta-analysis of non-invasive gastrointestinal markers. Molecular Autism 15:1.
Crossref
Crossref
舒 陈. (2024) Progress in Biomarkers of Inflammatory Bowel Disease. Advances in Clinical Medicine 14:03, pages 1418-1428.
Crossref
Crossref
Bushra Riaz & Seonghyang Sohn. (2023) Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity. Cells 12:22, pages 2621.
Crossref
Crossref
Maiss Reghefaoui, Tariladei S Peresuodei, Michell S Saavedra Palacios, Abhishek Gill, Chijioke Orji, Tiba Reghefaoui & Jihan Mostafa. (2023) The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease. Cureus.
Crossref
Crossref
Ondrej Fabian, Lukas Bajer, Pavel Drastich, Karel Harant, Eva Sticova, Nikola Daskova, Istvan Modos, Filip Tichanek & Monika Cahova. (2023) A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review. International Journal of Molecular Sciences 24:11, pages 9386.
Crossref
Crossref
Anto Sam Crosslee Louis Sam Titus, Kamala Vanarsa, Sanam Soomro, Anjali Patel, Jarod Prince, Subra Kugathasan & Chandra Mohan. (2023) Resistin, Elastase, and Lactoferrin as Potential Plasma Biomarkers of Pediatric Inflammatory Bowel Disease Based on Comprehensive Proteomic Screens. Molecular & Cellular Proteomics 22:2, pages 100487.
Crossref
Crossref
Lushun Ma, Xinyuan PangGuofeng Ji, Xinrui Ma, Jie Li, Yuan Chang & Chong Ma. (2021) Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis. Medicine 100:42, pages e27551.
Crossref
Crossref
Yingqi Zhang, Chao Lu & Jin Zhang. (2021) Lactoferrin and Its Detection Methods: A Review. Nutrients 13:8, pages 2492.
Crossref
Crossref
M.S. Ismail, Serhiy Semenov & Deirdre McNamara. (2021) The utility of faecal and urine biomarkers for small bowel diseases. Current Opinion in Gastroenterology 37:3, pages 284-294.
Crossref
Crossref
Peng Fei, Junliang Chen, Yichao Jiang, Hongjian Bai, Yanyan Wang, Ying Han, Min Xing & Ling Guo. (2021) Rotavirus-Induced Diarrhea Changes the Proteins, Amino Acids and Fatty Acids Profiles in Fecal Samples of the Infants. Iranian Journal of Pediatrics 31:1.
Crossref
Crossref
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano & Giovanni Latella. (2021) Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?. Digestion 102:6, pages 833-844.
Crossref
Crossref
Shno Asad, Christine Wegler, David Ahl, Christel A.S. Bergström, Mia Phillipson, Per Artursson & Alexandra Teleki. (2021) Proteomics-Informed Identification of Luminal Targets For In Situ Diagnosis of Inflammatory Bowel Disease. Journal of Pharmaceutical Sciences 110:1, pages 239-250.
Crossref
Crossref
Cong Dai, Min Jiang, Ming-Jun Sun & Qin Cao. (2020) Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity. Journal of Clinical Gastroenterology 54:6, pages 545-553.
Crossref
Crossref
Karim Arafah, Mark Kriegsmann, Marcus Renner, Felix Lasitschka, Margaux Fresnais, Katharina Kriegsmann, Moritz von Winterfeld, Benjamin Goeppert, Jörg Kriegsmann, Rita Casadonte, Daniel Kazdal, Philippe Bulet & Rémi Longuespée. (2020) Microproteomics and Immunohistochemistry Reveal Differences in Aldo‐Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease. PROTEOMICS – Clinical Applications 14:4.
Crossref
Crossref
Jiani Wang, Christina Ortiz, Lindsey Fontenot, Ying Xie, Wendy Ho, S. Anjani Mattai, David Q. Shih & Hon Wai Koon. (2020) High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures. PLOS ONE 15:4, pages e0231796.
Crossref
Crossref
James M. Gray, Kristin Knight, Vu Q. Nguyen, Marrieth G. Rubio, Lauren Irby, James H. Boone & Dario Sorrentino. (2020) Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases 5:3, pages 151-158.
Crossref
Crossref
Marrieth G Rubio, Kofi Amo-Mensah, James M Gray, Vu Q Nguyen, Sam Nakat, Douglas Grider, Kim Love, James H Boone & Dario Sorrentino. (2019) Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease. World Journal of Gastrointestinal Pathophysiology 10:5, pages 54-63.
Crossref
Crossref
Claudia Deutschmann, Mandy Sowa, Jayaseelan Murugaiyan, Uwe Roesler, Nadja Röber, Karsten Conrad, Martin W Laass, Dimitrios Bogdanos, Nora Sipeki, Maria Papp, Stefan Rödiger, Dirk Roggenbuck & Peter Schierack. (2019) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s Disease. Journal of Crohn's and Colitis 13:7, pages 894-904.
Crossref
Crossref
Maria Stefania Lepanto, Luigi Rosa, Rosalba Paesano, Piera Valenti & Antimo Cutone. (2019) Lactoferrin in Aseptic and Septic Inflammation. Molecules 24:7, pages 1323.
Crossref
Crossref
Honghui Zhou & Diane R. MouldReena Khanna & Brian G. Feagan. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases
25
42
.
Matthias Hübenthal, Andre Franke, Simone Lipinski & Simonas Juzėnas. 2019. Molecular Genetics of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease
203
230
.
Robert N Lopez, Steven T Leach, Daniel A Lemberg, Gilles Duvoisin, Richard B Gearry & Andrew S Day. (2017) Fecal biomarkers in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 32:3, pages 577-582.
Crossref
Crossref
Khadija H. Chaudrey & Edward V. LoftusJr.Jr.. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
45
59
.
Fernando Magro, Susana Isabel Lopes, Joanne Lopes, Francisco Portela, José Cotter, Sandra Lopes, Maria João Moreira, Paula Lago, Paula Peixe, Andreia Albuquerque, Susana Rodrigues, Mário Rui Silva, Pedro Monteiro, Castro Lopes, Lucília Monteiro, Guilherme Macedo, Luís Veloso, Claudia Camila, J. Afonso, Karel Geboes & Fátima Carneiro. (2016) Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab. Journal of Crohn's and Colitis 10:12, pages 1407-1416.
Crossref
Crossref
Anna‐Maija Puolanne, Kaija‐Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2016) Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease. European Journal of Clinical Investigation 46:10, pages 825-832.
Crossref
Crossref
Anet A. Soubières & Andrew Poullis. (2016) Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 22:8, pages 2016-2022.
Crossref
Crossref
Emily K. Wright, Michael A. Kamm, Peter De Cruz, Amy L. Hamilton, Kathryn J. Ritchie, Jacqueline I. Keenan, Steven Leach, Laura Burgess, Alan Aitchison, Alexandra Gorelik, Danny Liew, Andrew S. Day & Richard B. Gearry. (2016) Comparison of Fecal Inflammatory Markers in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1086-1094.
Crossref
Crossref
Anet A Soubières. (2016) Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 41.
Crossref
Crossref
Chi‐Huan Wu, Tsung‐Hsing Chen, Chun‐Yen Lin, Cheng‐Hsun Chiu, Ming‐Yao Su & Cheng‐Tang Chiu. (2015) Analysis of ascitic fluid lactoferrin levels in the diagnosis of spontaneous bacterial peritonitis after systemic antibiotic treatment. Advances in Digestive Medicine 2:4, pages 123-127.
Crossref
Crossref
Weiwei Jiang & Xuhang Li. (2015) Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 19:3, pages 141-158.
Crossref
Crossref
Frank S. Lehmann, Emanuel Burri & Christoph Beglinger. (2014) The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 8:1, pages 23-36.
Crossref
Crossref
Xing-lu Zhou, Wen Xu, Xiao-xiao Tang, Lai-sheng Luo, Jiang-feng Tu, Chen-jing Zhang, Xiang Xu, Qin-dong Wu & Wen-sheng Pan. (2014) Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis. BMC Gastroenterology 14:1.
Crossref
Crossref
Uri Kopylov, Greg Rosenfeld, Brian Bressler & Ernest Seidman. (2014) Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:4, pages 742-756.
Crossref
Crossref
Yi Fengming & Wu Jianbing. (2014) Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014, pages 1-11.
Crossref
Crossref
Michelle Vu & Daniel W. Hommes. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
457
467
.
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka & Robert Logan. (2013) Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis 7:8, pages 670-677.
Crossref
Crossref
Emanuel Burri, Michael Manz, Claude Rothen, Livio Rossi, Christoph Beglinger & Frank Serge Lehmann. (2013) Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clinica Chimica Acta 416, pages 41-47.
Crossref
Crossref
Taina Sipponen. (2013) Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin. Digestive Diseases 31:3-4, pages 336-344.
Crossref
Crossref
J. Matricon, M. Meleine, A. Gelot, T. Piche, M. Dapoigny, E. Muller & D. Ardid. (2012) Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1009-1031.
Crossref
Crossref
Roy A Sherwood. (2012) Faecal markers of gastrointestinal inflammation. Journal of Clinical Pathology 65:11, pages 981-985.
Crossref
Crossref
Larry Smarr. (2012) Quantifying your body: A how‐to guide from a systems biology perspective. Biotechnology Journal 7:8, pages 980-991.
Crossref
Crossref
Radu M. Nanau & Manuela G. Neuman. (2012) Metabolome and inflammasome in inflammatory bowel disease. Translational Research 160:1, pages 1-28.
Crossref
Crossref
Bincy P. Abraham & Sunanda Kane. (2012) Fecal Markers: Calprotectin and Lactoferrin. Gastroenterology Clinics of North America 41:2, pages 483-495.
Crossref
Crossref
Ruth M Ayling. (2011) New faecal tests in gastroenterology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 49:1, pages 44-54.
Crossref
Crossref
Thomas A Judd, Andrew S Day, Daniel A Lemberg, Dan Turner & Steven T Leach. (2011) Update of fecal markers of inflammation in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 26:10, pages 1493-1499.
Crossref
Crossref
N. V. Filipenko. (2010) NONINVASIVE DIAGNOSIS OF ULCERATIVE COLITIS ON THE BASIS OF FECAL LACTOFERRIN AND IMMUNOCHEMICAL HEMOCCULT TEST. Health and Ecology Issues:4, pages 144-151.
Crossref
Crossref
R. Sidhu, P. Wilson, L. Foye, M. E. McAlindon, A. J. Lobo, S. Morley & D. S. Sanders. (2010) Can faecal lactoferrin be used as a discriminator for referral for colonoscopy?. Internal Medicine Journal 40:12, pages 867-868.
Crossref
Crossref
Giulia Roda, Alessandra Caponi, Marco Benevento, Paolo Nanni, Laura Mezzanotte, Andrea Belluzzi, Lloyd Mayer & Aldo Roda. (2010) New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflammatory Bowel Diseases 16:7, pages 1239-1246.
Crossref
Crossref
R. SIDHU, P. WILSON, A. WRIGHT, C. W. H. YAU, F. A. D’CRUZ, L. FOYE, S. MORLEY, A. J. LOBO, M. E. MCALINDON & D. S. SANDERS. (2010) Faecal lactoferrin – a novel test to differentiate between the irritable and inflamed bowel?. Alimentary Pharmacology & Therapeutics 31:12, pages 1365-1370.
Crossref
Crossref
Cansel Turkay & Benan Kasapoglu. (2010) Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics 65:2, pages 221-231.
Crossref
Crossref
Javier P. Gisbert, Adrian G. McNicholl & Fernando Gomollon. (2009) Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases 15:11, pages 1746-1754.
Crossref
Crossref
Tetsuo Hayakawa, Chun Xiang Jin, Shigeru B. H. KO, Motoji Kitagawa & Hiroshi Ishiguro. (2009) Lactoferrin in Gastrointestinal Disease. Internal Medicine 48:15, pages 1251-1254.
Crossref
Crossref
T. SIPPONEN, P. KÄRKKÄINEN, E. SAVILAHTI, K.‐L. KOLHO, H. NUUTINEN, U. TURUNEN & M. FÄRKKILÄ. (2008) Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Alimentary Pharmacology & Therapeutics 28:10, pages 1221-1229.
Crossref
Crossref